NEW YORK (GenomeWeb News) - Solexa appointed Frank Oaks as vice president of DNA sequencing services, the company said yesterday.
Oaks joined Solexa from Applied Biosystems’ Genetic Analysis Group. At ABI in a variety of positions since 1992, he was most recently director of scientific operations. Prior to ABI, he was a research scientist with Dow Chemical.
He holds a PhD in organic chemistry from the University of Wisconsin, a BS in chemistry from the University of California, Los Angeles, and an MBA from Santa Clara University.
In July Solexa named Brock Siegel as chief operating officer. Siegel had spent the past 15 years with ABI in a variety of senior management positions. Also in July, Solexa named Richard Lussier to the newly created position of vice president of sales and field operations. Lussier had been president and general manager of ABI Japan for five years and held other managerial positions in US, Japanese, and other Asian field organizations for the Applera unit.
Also, CEO John West joined Solexa from ABI, where he was vice president of DNA Platforms; Peter Lundverg, Solexa’s vice president and chief technical officer, was vice president of DNA Platforms R&D at ABI; Kathy San Roman, Solexa’s vice president of human resource and administration, held “numerous” positions at ABI; and Omead Ostodan, vice president of marketing at Solexa, was ABI’s senior product line manager for gene-expression platforms where, among other things, he was responsible for the company’s 3700, 3730xl instruments.
Mary-Claire King received the 2006 Weizmann Women & Science Award from the American Committee for the Weizmann Institute of Science, the group said on Wednesday.
King, a geneticist, first discovered that the human and chimpanzee genomes have genes that are 99 percent identical. She also reported in 1990 that the BRCA1 gene can run in families to predispose women to breast cancer. Her recent work focused on forensics science, using DNA to identify bodies.
Established in 1994, the biennial $25,000 award honors outstanding women scientists in the US who have made a major contribution in science, technology, or engineering.
Clinical Data named C. Evan Ballantyne as senior vice president and chief financial officer.
He replaces Israel M. Stein, the interim chief financial officer.
Ballantyne comes to Clinical Data from ZymeQuest, where he was a senior vice-president and CFO. He was CFO of Knowledge Impact, prior to ZymeQuest. At ACNielsen, he held various positions, including vice president, chief operating officer, and chief financial officer.
He received his BA from the University of Western Ontario and took a post-graduate degree in business administration with honors from the University of Windsor.
Bruker BioSciences’ board of directors modified the compensation plan for non-employee directors on Aug. 1, the company said in documents filed with the Securities and Exchange Commission on Monday.
The annual retainer for non-employee directors increased to $26,000 from $16,000, the filing said. Each non-employee director will also receive a payment of $1,500 per board meeting the director attends, either in-person or by phone. They will continue to receive stock options.
The audit committee’s chairman receives an additional cash retainer, the amount of which increased to $28,000 from $18,000. The additional retainer the other members of the committee receive increased to $13,000 from $6,000.
The compensation committee’s chairman also receives an additional cash retainer, which increased to $13,000 from $6,000. The other committee members’ retainers increase to $8,000 from $4,000.
GE appointed Michael Barber, Robert Green, and Nancy Loewe as vice presidents, the company said on Tuesday.
Barber was named the chief technology officer of GE Healthcare and a vice president of technology, diagnostic imaging. He has been the general manager of technology since May 2005 and has been with GE since 1981. He held other positions in GE Healthcare, including general manager for components engineering and general manager for global components operations.
Barber received his bachelors' degree in electrical engineering from the Milwaukee School of Engineering.
Green was named chief financial officer of GE Money, Americas, and senior vice-president. He was name the CFO for the Americas since March 2006, the company said. Two years prior, he was the CFO for the Biosciences unit within GE Healthcare. He received his bachelors' degree in finance from the University of Maryland.
Loewe was named chief financial officer, consumer and industrial, for GE Industrial, and vice president. Loewe became the CFO for Consumer & Industrial in August 2005, the company said. Loewe held a number of positions in GE Healthcare and GE Industrial, including CFO for GE Plastic's Pacific pole, and CFO for healthcare services within GE Healthcare.
Loewe received her MBA from University of Massachusetts.
NimbleGen Systems named David Snyder as chief financial officer on Monday.
He has over 15 years experience as a chief financial officer for companies spanning several industries, including technology, real estate, and diversified manufacturing.
Snyder graduated from the Harvard Business School with high honors and was designated a Baker Scholar. He received his BA from Ottawa University.
DNAPrint Genomics retained Arthur Stytkowski as a consultant on scientific, medical, regulatory, and patent issues, the company said Tuesday.
Stytkowski is the director of the laboratory for cell and molecular biology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He is an associate professor in the department of medicine at the Harvard Medical School and a member of the division of hematology and oncology at BIDMC.